Stock 002422 SICHUAN KELUN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sichuan Kelun Pharmaceutical Co., Ltd.

Equities

002422

CNE100000PW7

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 03:30:00 09/05/2024 am IST 		5-day change 1st Jan Change
34.79 CNY +3.45% Intraday chart for Sichuan Kelun Pharmaceutical Co., Ltd. +2.47% +19.76%
25/04 Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
10/04 Sichuan Kelun Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Sichuan Kelun Pharmaceutical Co., Ltd. specializes in developing, manufacturing and marketing pharmaceuticals. Net sales break down by activity as follows:

- manufacturing and sale of pharmaceutical products (98%). Net sales break down by family of products between injectable drugs (56.9%) and other (43.1%; tablets, capsules, granules, etc.);

- other (2%).

China accounts for 94.6% of net sales.

Number of employees: 19,798

Sales per Business

CNY in Million2022Weight2023Weight Delta
Transfusion
47.1 %
9,452 50.0 % 10,109 47.1 % +6.96%
Non-transfusion
42.2 %
8,274 43.7 % 9,057 42.2 % +9.46%
Research and Development Projects
7.2 %
752 4.0 % 1,548 7.2 % +105.95%
Other
3.4 %
435 2.3 % 740 3.4 % +69.88%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
87.9 %
17,512 92.6 % 18,866 87.9 % +7.73%
International
12.1 %
1,401 7.4 % 2,588 12.1 % +84.80%

Managers

Managers TitleAgeSince
Si Chuan Liu CEO
 Chief Executive Officer 40 26/09/26
Ge Xin Liu FOU
 Founder 73 01/96/01
De Gui Lai DFI
 Director of Finance/CFO 52 01/01/01
Peng Wan CHM
 Chairman 48 01/01/01
Xin Huang IRC
 Investor Relations Contact - -
Hao Feng IRO
 Public Communications Contact 44 24/14/24
Hong Bo Tan PRN
 Corporate Officer/Principal 53 19/13/19

Members of the board

Members of the board TitleAgeSince
Ge Xin Liu FOU
 Founder 73 01/96/01
Guang Ji Wang BRD
 Director/Board Member 71 01/18/01
Yun Pei Guo BRD
 Director/Board Member 76 22/16/22
Si Chuan Liu CEO
 Chief Executive Officer 40 26/09/26
Peng Wan CHM
 Chairman 48 01/01/01
Guo Sheng He BRD
 Director/Board Member 56 01/14/01
Chang Yan Zheng BRD
 Director/Board Member 50 01/97/01
Ming Gang Ou BRD
 Director/Board Member 57 24/22/24
Shi Chi Ren BRD
 Director/Board Member 54 29/21/29
Jin Bo Gao BRD
 Director/Board Member 64 29/21/29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,601,592,173 1,072,158,372 ( 66.94 %) 6,040,983 ( 0.3772 %) 66.94 %

Shareholders

NameEquities%Valuation
Ge Xin Liu
8.090 %
94,782,070 8.090 % 401 M ¥
Ya'an State-Owned Assets Supervision & Administration
8.006 %
93,801,074 8.006 % 396 M ¥
Si Chuan Liu
2.646 %
30,996,886 2.646 % 131 M ¥
Shanghai Yongjin Investment & Management Co., Ltd.
2.383 %
27,916,896 2.383 % 118 M ¥
Bosera Asset Management Co., Ltd.
1.999 %
23,418,187 1.999 % 99 M ¥
HuaAn Fund Management Co., Ltd.
1.675 %
19,627,681 1.675 % 83 M ¥
Hui Pan
1.419 %
16,631,100 1.419 % 70 M ¥
Ya Guang Liu
1.290 %
15,119,962 1.290 % 64 M ¥
Feng Gang Yin
1.234 %
14,458,532 1.234 % 61 M ¥
China Southern Asset Management Co., Ltd.
1.152 %
13,499,893 1.152 % 57 M ¥
NameEquities%Valuation
Ge Xin Liu
96.46 %
284,346,210 96.46 % 1 202 M ¥

Holdings

NameEquities%Valuation
YILI CHUANNING BIOTECHNOLOGY CO.,LTD.
97.52%
 1,569,887,643 97.52% 1,998,341,379 $
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
52.66%
 78,777,842 52.66% 1,560,166,801 $
SSY GROUP LIMITED
20.43%
 606,722,000 20.43% 400,011,815 $
CISEN PHARMACEUTICAL CO., LTD.
10.07%
 45,335,300 10.07% 90,075,348 $
SICHUAN KELUN PHARMACEUTICAL CO., LTD.
0.91%
 10,716,165 0.91% 45,296,586 $

Company contact information

Sichuan Kelun Pharmaceutical Co., Ltd.

36 West Baihua Road Qingyang District

610071, Chengdu

+86 28 8612 7705

http://www.kelun.com
address Sichuan Kelun Pharmaceutical Co., Ltd.(002422)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Sichuan Kelun Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
34.79 CNY
Average target price
42.04 CNY
Spread / Average Target
+20.84%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SICHUAN KELUN PHARMACEUTICAL CO., LTD. Stock Sichuan Kelun Pharmaceutical Co., Ltd.
+19.76% 7.4B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.36% 698B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.40% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.46% 328B
ABBVIE INC. Stock AbbVie Inc.
+3.50% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.34% 238B
NOVARTIS AG Stock Novartis AG
+6.68% 203B
ROCHE HOLDING AG Stock Roche Holding AG
-9.08% 198B
AMGEN INC. Stock Amgen Inc.
+8.62% 165B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002422 Stock
  4. Company Sichuan Kelun Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW